Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19
Perrine Janiaud, Cathrine Axfors, Andreas M. Schmitt, et al.
JAMA (2021) Vol. 325, Iss. 12, pp. 1185-1185
Open Access | Times Cited: 227

Showing 1-25 of 227 citing articles:

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta, Khai Li Chai, Sarah J Valk, et al.
Cochrane library (2020)
Open Access | Times Cited: 327
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100794-100794
Open Access | Times Cited: 262
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
Hesham Abdelhady, Marwa Abdelrazik, Zakee Abdi, et al.
JAMA (2021) Vol. 326, Iss. 17, pp. 1690-1690
Open Access | Times Cited: 188
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta, Claire Iannizzi, Khai Li Chai, et al.
Cochrane library (2021) Vol. 2021, Iss. 5
Open Access | Times Cited: 188
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, et al.
PLoS Medicine (2021) Vol. 18, Iss. 7, pp. e1003656-e1003656
Open Access | Times Cited: 140
Early Convalescent Plasma for High-Risk Outpatients with Covid-19
Frederick K. Korley, Valerie Durkalski‐Mauldin, Sharon D. Yeatts, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 21, pp. 1951-1960
Open Access | Times Cited: 140
Therapeutic advances in COVID-19
Naoka Murakami, Robert Hayden, Thomas Hills, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 38-52
Open Access | Times Cited: 128
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)
Simone Cesaro, Per Ljungman, Małgorzata Mikulska, et al.
Leukemia (2022) Vol. 36, Iss. 6, pp. 1467-1480
Open Access | Times Cited: 105
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 89
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial
Andrea Alemany, Pere Millat-Martínez, Marc Corbacho-Monné, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 3, pp. 278-288
Open Access | Times Cited: 78
Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19
Sixten Körper, Manfred Weiß, Daniel Zickler, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 20
Open Access | Times Cited: 82
An update of anti-viral treatment of COVID-19
Serap Şimşek Yavuz, İpek Komşuoğlu Çelikyurt
TURKISH JOURNAL OF MEDICAL SCIENCES (2021) Vol. 51, Iss. SI-1, pp. 3372-3390
Open Access | Times Cited: 78
Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
Leo Sekine, Beatriz Arns, Bruna R. Fabro, et al.
European Respiratory Journal (2021) Vol. 59, Iss. 2, pp. 2101471-2101471
Open Access | Times Cited: 67
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial
Mark N. Polizzotto, Jacqueline Nordwall, Abdel G. Babiker, et al.
The Lancet (2022) Vol. 399, Iss. 10324, pp. 530-540
Open Access | Times Cited: 65
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
Stephen A. Klassen, Jonathon W. Senefeld, Katherine A. Senese, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 64
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis
Thomas Hueso, Anne-Sophie Godron, Émilie Lanoy, et al.
Leukemia (2022) Vol. 36, Iss. 4, pp. 1025-1034
Open Access | Times Cited: 61
Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality
Arturo Casadevall, Quigly Dragotakes, Patrick W. Johnson, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 59
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
Cathrine Axfors, Perrine Janiaud, Andreas M. Schmitt, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 59
Traditional herbs against COVID-19: back to old weapons to combat the new pandemic
Hayder M. Al‐kuraishy, Omnia Momtaz Al-Fakhrany, Engy Elekhnawy, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 53
Comparative effectiveness of N95, surgical or medical, and non‐medical facemasks in protection against respiratory virus infection: A systematic review and network meta‐analysis
Min Seo Kim, Dawon Seong, Han Li, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 49
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19
Andrea B. Troxel, Eva Petkova, Keith Goldfeld, et al.
JAMA Network Open (2022) Vol. 5, Iss. 1, pp. e2147331-e2147331
Open Access | Times Cited: 45
Honey and Nigella sativa against COVID‐19 in Pakistan (HNS‐COVID‐PK): A multicenter placebo‐controlled randomized clinical trial
Sohaib Ashraf, Shoaib Ashraf, Moneeb Ashraf, et al.
Phytotherapy Research (2022) Vol. 37, Iss. 2, pp. 627-644
Closed Access | Times Cited: 41
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Misinformation and Disinformation: The Potential Disadvantages of Social Media in Infectious Disease and How to Combat Them
Angel N. Desai, Diandra Ruidera, Julie M. Steinbrink, et al.
Clinical Infectious Diseases (2022) Vol. 74, Iss. Supplement_3, pp. e34-e39
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top